• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

臀中肌转移的肝细胞癌治疗:1例病例报告及文献复习

Treatment of hepatocellular carcinoma with gluteus medius metastasis: a case report and a literature review.

作者信息

Li Yanxin, Luo Ji, Zhang Jianyong, Sun Mingqiang, Yang Jinping

机构信息

Department of Oncology, First People's Hospital of Guangyuan, Guangyuan, China.

Department of Obstetrics and Gynecology, The First People's Hospital of Guangyuan, Guangyuan, China.

出版信息

Front Oncol. 2025 May 1;15:1329756. doi: 10.3389/fonc.2025.1329756. eCollection 2025.

DOI:10.3389/fonc.2025.1329756
PMID:40376579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079037/
Abstract

Hepatocellular carcinoma (HCC) accounts for 85%-90% of all primary liver cancers (PLCs). Owing to the occult nature of HCC, most patients present at an advanced stage at the time of initial diagnosis and have a poor prognosis. With regard to systemic therapy, targeted therapy and immunotherapy are currently the centers of clinical research. With regard to local treatment, surgical resection, radiofrequency ablation, hepatic artery chemoembolization, and radiotherapy are commonly used. Interstitial brachytherapy is commonly used for the treatment of cervical and genitourinary cancers. In this case, interstitial brachytherapy was used to treat gluteus medius muscle metastasis from PLC, with good local control and symptom relief.

摘要

肝细胞癌(HCC)占所有原发性肝癌(PLC)的85%-90%。由于HCC具有隐匿性,大多数患者在初诊时已处于晚期,预后较差。在全身治疗方面,靶向治疗和免疫治疗是目前临床研究的重点。在局部治疗方面,手术切除、射频消融、肝动脉化疗栓塞和放射治疗是常用的方法。间质近距离放射治疗常用于治疗宫颈癌和泌尿生殖系统癌症。在本病例中,间质近距离放射治疗被用于治疗PLC的臀中肌转移,局部控制良好,症状得到缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/b4a92eacc9bb/fonc-15-1329756-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/1a56fb643b38/fonc-15-1329756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/be644518d6aa/fonc-15-1329756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/ede78e9a8f9b/fonc-15-1329756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/92d0ce89f42a/fonc-15-1329756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/6a065f74fdc6/fonc-15-1329756-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/f0f3c7d2098f/fonc-15-1329756-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/b4a92eacc9bb/fonc-15-1329756-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/1a56fb643b38/fonc-15-1329756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/be644518d6aa/fonc-15-1329756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/ede78e9a8f9b/fonc-15-1329756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/92d0ce89f42a/fonc-15-1329756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/6a065f74fdc6/fonc-15-1329756-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/f0f3c7d2098f/fonc-15-1329756-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/417c/12079037/b4a92eacc9bb/fonc-15-1329756-g007.jpg

相似文献

1
Treatment of hepatocellular carcinoma with gluteus medius metastasis: a case report and a literature review.臀中肌转移的肝细胞癌治疗:1例病例报告及文献复习
Front Oncol. 2025 May 1;15:1329756. doi: 10.3389/fonc.2025.1329756. eCollection 2025.
2
Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.经皮局部消融治疗肝细胞癌的最新进展。
Rofo. 2022 Oct;194(10):1075-1086. doi: 10.1055/a-1768-0954. Epub 2022 May 11.
3
[Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].[射频消融联合经动脉化疗栓塞治疗肝细胞癌肾上腺转移瘤切除术后局部复发性肿瘤——病例报告]
Gan To Kagaku Ryoho. 2009 Nov;36(12):2371-3.
4
Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.免疫疗法治疗肝细胞癌:当前与未来选择的综述
J Clin Transl Hepatol. 2020 Jun 28;8(2):168-176. doi: 10.14218/JCTH.2020.00001. Epub 2020 Jun 10.
5
Complete response by patients with advanced hepatocellular carcinoma after combination immune/targeted therapy and transarterial chemoembolization: two case reports and literature review.晚期肝细胞癌患者在免疫/靶向联合治疗及经动脉化疗栓塞后的完全缓解:两例病例报告及文献综述
Transl Cancer Res. 2022 Aug;11(8):2973-2984. doi: 10.21037/tcr-21-2691.
6
Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.肝细胞癌非手术治疗的当前标准与未来展望
Digestion. 2017;96(1):1-4. doi: 10.1159/000464282. Epub 2017 Jun 13.
7
8
Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report.晚期肝细胞癌伴肺转移的局部治疗完全缓解:一例报告
J Liver Cancer. 2022 Mar;22(1):51-56. doi: 10.17998/jlc.2021.12.28. Epub 2022 Jan 27.
9
Advances in non-surgical management of primary liver cancer.原发性肝癌非手术治疗的进展
World J Gastroenterol. 2014 Nov 28;20(44):16630-8. doi: 10.3748/wjg.v20.i44.16630.
10
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.经动脉化疗栓塞术在肝细胞癌治疗中的应用:巴塞罗那临床肝癌分期系统
World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327.

本文引用的文献

1
Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis.肿瘤相关淋巴管密度是肝胆癌术后的预后生物标志物:一项系统评价和荟萃分析。
Front Immunol. 2025 Jan 7;15:1519999. doi: 10.3389/fimmu.2024.1519999. eCollection 2024.
2
Portal Venous and Hepatic Arterial Coefficients Predict Post-Hepatectomy Overall and Recurrence-Free Survival in Patients with Hepatocellular Carcinoma: A Retrospective Study.门静脉和肝动脉系数预测肝细胞癌患者肝切除术后的总生存率和无复发生存率:一项回顾性研究
J Hepatocell Carcinoma. 2024 Jul 9;11:1389-1402. doi: 10.2147/JHC.S462168. eCollection 2024.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Image-guided intensity-modulated radiotherapy improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma.图像引导调强放疗可改善肝细胞癌腹部淋巴结转移患者的短期生存率。
Ann Palliat Med. 2019 Nov;8(5):717-727. doi: 10.21037/apm.2019.11.17.
5
Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.日本第20次全国原发性肝癌随访调查结果报告。
Hepatol Res. 2020 Jan;50(1):15-46. doi: 10.1111/hepr.13438. Epub 2020 Jan 5.
6
Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial.肝癌合并门静脉癌栓患者术后辅助 IMRT:一项开放标签随机对照试验。
Radiother Oncol. 2019 Nov;140:20-25. doi: 10.1016/j.radonc.2019.05.006. Epub 2019 Jun 5.
7
Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.不可切除肝细胞癌经动脉化疗栓塞术后行立体定向体部放疗可提高生存率:一项倾向评分匹配分析。
Surg Oncol. 2019 Mar;28:228-235. doi: 10.1016/j.suronc.2019.01.006. Epub 2019 Jan 29.
8
Solitary Muscle Metastasis of Hepatocellular Carcinoma to the Biceps Femoris Muscle with Only Elevated Serum PIVKA-II: A Case Report.仅血清异常凝血酶原升高的肝细胞癌孤立性股二头肌肌肉转移:一例报告
Am J Case Rep. 2019 Mar 8;20:306-309. doi: 10.12659/AJCR.913730.
9
Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.放疗治疗肝细胞癌的生存结果与射频消融相当:一项倾向评分分析。
Hepatology. 2019 Jun;69(6):2533-2545. doi: 10.1002/hep.30591. Epub 2019 May 2.
10
Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.立体定向体部放疗治疗肝细胞癌的临床可行性和疗效:一项观察性研究的系统评价和荟萃分析。
Radiother Oncol. 2019 Feb;131:135-144. doi: 10.1016/j.radonc.2018.12.005. Epub 2018 Dec 31.